Prevalence, awareness, treatment and control of hypertension in a Canarian population.: Relationship with glucose tolerance categories.: The Guia Study

被引:9
作者
de Pablos-Velasco, P [1 ]
Martínez-Martín, FJ
Pérez, FR
Urioste, LMR
Robles, RG
机构
[1] Hosp Gen Gran Canaria Dr Negrin, Dept Endocrinol, Las Palmas Gran Canaria 35011, Spain
[2] Hosp Gen Gran Canaria Dr Negrin, Qual Dept, Las Palmas Gran Canaria 35011, Spain
[3] Hosp Doce De Octubre, Dept Nephrol, Hypertens Unit, Madrid, Spain
[4] Hosp Ramon & Cajal, Dept Endocrinol, E-28034 Madrid, Spain
关键词
diabetes mellitus; epidemiology; high blood pressure; impaired glucose tolerance; population study;
D O I
10.1097/00004872-200210000-00015
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To estimate the prevalence, awareness, treatment and control of hypertension in a Canarian population; and their relationship with the glucose tolerance categories. Design From a population of 6355 subjects over 29 years old, 690 were chosen in a random sampling. Blood pressure measurements, a standard oral glucose tolerance test (excluding known diabetic patients), and a questionnaire on diabetes and hypertension history and medication use was performed. Results The total prevalence of hypertension was 50.3%; 62.0% of the hypertensive subjects were aware of their condition; 60.6% had their diastolic and 11.0% their systolic blood pressure controlled and 8.6% had both. For diabetic, glucose intolerant and normoglycemic subjects, the respective prevalences of hypertension were 79.4, 60.2 and 43.1% (higher in diabetic subjects, P < 0.001); the awareness of hypertension was 66.7, 61.8 and 59.5% (differences not significant); systolic blood pressure control was 4.8,14.7 and 13.7% (lower in diabetic subjects, P = 0.017 versus glucose intolerant and P = 0.011 versus normoglycemic subjects); diastolic blood pressure control was 50.4, 72.1 and 63.2% (lower in diabetic subjects, P = 0.004 versus glucose intolerant and P= 0.025 versus normoglycemic subjects). There were no differences in the number and type of antihypertensive drugs among the different glucose tolerance categories. Conclusions Blood pressure was comparable in our population and in other European populations. The prevalence of hypertension was higher, the awareness was similar, and control was worse in diabetic than in nondiabetic subjects; the drug treatment pattern was not different. J Hypertens 20:1965-1971 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1965 / 1971
页数:7
相关论文
共 45 条
[1]  
Ahmad O, 2000, GPE DISCUSSION PAPER, V31
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
Barco LC, 1998, MED CLIN-BARCELONA, V110, P328
[5]   Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [J].
Barzilay, JI ;
Jones, CL ;
Davis, BR ;
Basile, JN ;
Goff, DC ;
Ciocon, JO ;
Sweeney, ME ;
Randall, OS .
DIABETES CARE, 2001, 24 (04) :654-658
[6]  
Birkenhäger WH, 2000, J NEPHROL, V13, P232
[7]  
Black HR, 1997, ARCH INTERN MED, V157, P2413
[8]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[9]   PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[10]  
Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009